{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:16:55Z","timestamp":1780503415709,"version":"3.54.1"},"reference-count":41,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.2169\/internalmedicine.5944-20","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T22:12:19Z","timestamp":1613340739000},"page":"15-22","source":"Crossref","is-referenced-by-count":9,"title":["Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure"],"prefix":"10.2169","volume":"61","author":[{"given":"Shuhei","family":"Tanaka","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Narang","sequence":"additional","affiliation":[{"name":"Advocate Christ Medical Center, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet 383: 1921-1932, 2014.","DOI":"10.1016\/S0140-6736(13)62145-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Udholm S, Nyboe C, Karunanithi Z, et al. Lifelong burden of small unrepaired atrial septal defect: results from the Danish National Patient Registry. Int J Cardiol 283: 101-106, 2019.","DOI":"10.1016\/j.ijcard.2019.02.024"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 323: 1645-1650, 1990.","DOI":"10.1056\/NEJM199012133232401"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Meijboom F, Hess J, Szatmari A, et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol 72: 1431-1434, 1993.","DOI":"10.1016\/0002-9149(93)90192-F"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 42: 388-393, 1997.","DOI":"10.1002\/(SICI)1097-0304(199712)42:4<388::AID-CCD7>3.0.CO;2-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fischer G, Kramer HH, Stieh J, Harding P, Jung O. Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder. Eur Heart J. 20: 541-549, 1999.","DOI":"10.1053\/euhj.1998.1330"},{"key":"7","unstructured":"7. Waight DJ, Koenig PR, Cao QL, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the Amplatzer Septal Occluder: clinical experience and technical considerations. Curr Interv Cardiol Rep 2: 70-77, 2000."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer I. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39: 1836-1844, 2002.","DOI":"10.1016\/S0735-1097(02)01862-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mylotte D, Quenneville SP, Kotowycz MA, et al. Long-term cost-effectiveness of transcatheter versus surgical closure of secundum atrial septal defect in adults. Int J Cardiol 172: 109-114, 2014.","DOI":"10.1016\/j.ijcard.2013.12.144"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rosas M, Zabal C, Garcia-Montes J, Buendia A, Webb G, Attie F. Transcatheter versus surgical closure of secundum atrial septal defect in adults: impact of age at intervention. A concurrent matched comparative study. Congenit Heart Dis 2: 148-155, 2007.","DOI":"10.1111\/j.1747-0803.2007.00091.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for secundum atrial septal defects in patients &gt;40 years old. A randomized clinical trial. J Am Coll Cardiol 38: 2035-2042, 2001.","DOI":"10.1016\/S0735-1097(01)01635-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Warnes CA, Williams RG, Bashore TM, et al. ACC\/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52: e143-e263, 2008.","DOI":"10.1161\/CIRCULATIONAHA.108.190690"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Umemoto S, Sakamoto I, Abe K, et al. Preoperative threshold for normalizing right ventricular volume after transcatheter closure of adult atrial septal defect. Circ J 84: 1312-1319, 2020.","DOI":"10.1253\/circj.CJ-20-0136"},{"key":"14","unstructured":"14. Baumgartner H, Bonhoeffer P, De Groot NM, et al.; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of C, Association for European Paediatric C, Guidelines ESCCfP, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31: 2915-2957, 2010."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ewert P, Berger F, Nagdyman N, et al. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 52: 177-180, 2001.","DOI":"10.1002\/1522-726X(200102)52:2<177::AID-CCD1043>3.0.CO;2-G"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 120: 198-204, 2007.","DOI":"10.1016\/j.ijcard.2006.09.017"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Balint OH, Samman A, Haberer K, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 94: 1189-1193, 2008.","DOI":"10.1136\/hrt.2006.114660"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zwijnenburg RD, Baggen VJM, Geenen LW, et al. The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: a systematic review. Am Heart J 201: 63-71, 2018.","DOI":"10.1016\/j.ahj.2018.03.020"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Gali\u00e8 N, Brundage BH, Ghofrani HA, et al. Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group: tadalafil therapy for pulmonary arterial hypertension. Circulation 119: 2894-2903, 2009.","DOI":"10.1161\/CIRCULATIONAHA.108.839274"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rubin LJ, Gali\u00e8 N, Grimminger F, et al. Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2). Eur Respir J 45: 1303-1313, 2015.","DOI":"10.1183\/09031936.00090614"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pulido T, Adzerikho I, Channick RN, et al. SERAPHIN Investigators: Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med  369: 809-818, 2013.","DOI":"10.1056\/NEJMoa1213917"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Trabattoni D, Gaspardone A, Sgueglia GA, et al. Amplatzer versus Figulla occluder for transcatheter patent foramen ovale closure. EuroIntervention 12: 2092-2099, 2017.","DOI":"10.4244\/EIJ-D-15-00499"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Numan M, El Sisi A, Tofeig M, Gendi S, Tohami T, El-Said HG. Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects. Pediatr Cardiol 29: 530-535, 2008.","DOI":"10.1007\/s00246-007-9079-x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Podnar T, Martanovic P, Gavora P, Masura J. Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv 53: 386-391, 2001.","DOI":"10.1002\/ccd.1187"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Fujii Y, Akagi T, Nakagawa K, et al. Clinical impact of transcatheter atrial septal defect closure on new onset atrial fibrillation in adult patients: comparison with surgical closure. J Cardiol 2020.","DOI":"10.1016\/j.jjcc.2020.01.008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Snijder RJR, Renes LE, Bosshardt D, Suttorp MJ, Ten Berg JM, Post MC. Percutaneous atrial septal defect closure using the Occlutech Figulla device in adults: more than 800 patient-years of follow-up. J Interv Cardiol 2020: 7136802, 2020.","DOI":"10.1155\/2020\/7136802"},{"key":"27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4244\/EIJV7I3A63","volume":"7","author":"G Butera","year":"2011","unstructured":"27. Butera G, Biondi-Zoccai G, Sangiorgi G, et al. Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7: 377-385, 2011.","journal-title":"EuroIntervention","ISSN":"https:\/\/id.crossref.org\/issn\/1774-024X","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr. Analysis of the US food and drug administration manufacturer and user facility device experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 137: 1334-1341, 2009.","DOI":"10.1016\/j.jtcvs.2009.02.032"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Amin Z, Hijazi ZM, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of regstry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63: 496-502, 2004.","DOI":"10.1002\/ccd.20211"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation 133: 1738-1746, 2016.","DOI":"10.1161\/CIRCULATIONAHA.115.019987"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. El-Said HG, Moore JW. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations?. Catheter Cardiovasc Interv 73: 925-930, 2009.","DOI":"10.1002\/ccd.21931"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Levi DS, Moore JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 61: 543-547, 2004.","DOI":"10.1002\/ccd.20011"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. El-Said H, Hegde S, Foerster S. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv 85: 227-233, 2015.","DOI":"10.1002\/ccd.25684"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Budts W, Troost E, Voigt JU, Gewillig M. Intra-cardiac echocardiography in atrial septal interventions: impact on hospitalization costs. Acta Cardiol 65: 147-152, 2010.","DOI":"10.2143\/AC.65.2.2047047"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Arslan \u015e, \u00c7a\u011f\u0131rc\u0131 G, Bayar N, et al. Corrected balloon occlusive diameter to determine device size during percutaneous atrial septal defect closure. Turk Kardiyol Dern Ars 43: 420-426, 2015.","DOI":"10.5543\/tkda.2015.68217"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Jang JY, Heo R, Cho MS, et al. Efficacy of 3D transoesophageal echocardiography for transcatheter device closure of atrial septal defect without balloon sizing. Eur Heart J Cardiovasc Imaging 19: 684-689, 2018.","DOI":"10.1093\/ehjci\/jex153"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Miranda WR, Hagler DJ, Reeder GS, et al. Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: hemodynamic and clinical findings. Catheter Cardiovasc Interv 93: 1069-1075, 2019.","DOI":"10.1002\/ccd.28150"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Takaya Y, Akagi T, Nakagawa K, et al. Clinical significance of septal malalignment for transcatheter closure of atrial septal defect. J Interv Cardiol 2020: 6090612, 2020.","DOI":"10.1155\/2020\/6090612"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Dalvi BV, Pinto RJ, Gupta A. New technique for device closure of large atrial septal defects. Catheter Cardiovasc Interv 64: 102-107, 2005.","DOI":"10.1002\/ccd.20248"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Varma C, Benson LN, Silversides C, et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc Interv 61: 131-139, 2004.","DOI":"10.1002\/ccd.10700"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Diab KA, Cao QL, Bacha EA, Hijazi ZM. Device closure of atrial septal defects with the Amplatzer septal occluder: safety and outcome in infants. J Thorac Cardiovasc Surg 134: 960-966, 2007.","DOI":"10.1016\/j.jtcvs.2007.06.018"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/1\/61_5944-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T03:14:56Z","timestamp":1641006896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/1\/61_5944-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5944-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"article-number":"5944-20"}}